查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602392

激活素 A 市场：按类型、按应用划分 - 2025-2030 年全球预测

Activin-A Market by Type (Activin A Human, Activin A Mouse/ Rat), Application (Academic Research, Commercial Research) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Activin A市值为2.628亿美元，预计到2024年将达到2.8773亿美元，复合年增长率为9.57%，到2030年将达到4.9854亿美元。

激活素A是TGF-β超家族的成员，已知在调节发炎、细胞增殖、凋亡和组织修復等多种生理过程中发挥关键作用，是製药和生物技术领域的重要药物。市场范围涵盖纤维化疾病、癌症、生殖医学和骨骼疾病等治疗应用的需求。激活素 A 主要用于医学研究和临床试验，作为研究分子途径的实验药物，为学术界、製药公司和生物技术公司的最终应用提供了广阔的前景。激活素 A 市场的成长主要受到生物医学研究的增加、对标靶治疗的兴趣日益增长以及对病理学状况的不断了解的影响。最新的机会在于基因治疗和个人化医疗的进步，激活素 A 有潜力用于开发新的治疗方法，特别是在罕见疾病和慢性发炎疾病方面。公司可以透过参与合作研究、投资医药应用研发以及与学术机构合作来抓住这些机会，以保持在这一领域的突破。然而，严格的监管通讯协定、高昂的研发成本以及医疗保健专业人员对潜在应用的认识较低等挑战可能会阻碍市场成长。目前的市场已经成熟，适合非侵入性诊断工具的创新以及可优化激活素 A 治疗效用的生物相似药的开拓。与激活素 A 路径相关的生物标记的鑑定开闢了新的研究和应用途径，有可能解决疾病诊断和转化医学中未满足的需求。总体而言，Activin A 市场尚处于起步阶段，但充满活力，需要创新和策略伙伴关係，以在潜在的监管和成本障碍中抓住新机会。

主要市场统计
基准年[2023] 2.628 亿美元
预测年份 [2024] 2.8773 亿美元
预测年份 [2030] 4.9854 亿美元
复合年增长率（%） 9.57%

市场动态：揭示快速发展的激活素 A 市场的关键市场洞察

供给和需求的动态交互作用正在改变激活素 A 市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 细胞疗法的需求不断增长
    • 激活素 A 的益处，包括中胚层诱导、神经元分化、骨重塑和造血
  • 市场限制因素
    • 製造高成本
  • 市场机会
    • 广泛的子适应症和可用的药物标靶
    • 製造工艺不断进步
  • 市场挑战
    • 摄取激活素 A 可能产生的副作用

波特五力：驾驭激活素 A 市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解激活素 A 市场的外部影响

外部宏观环境因素在塑造激活素 A 市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解 Activin A 市场的竞争状况

对 Activin A 市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵激活素 A 市场供应商的绩效评估

FPNV定位矩阵是评估Activin A市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了激活素 A 市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 Activin A 市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 细胞疗法的需求不断增长
      • 激活素 A 带来的益处包括中胚层诱导、神经元分化、骨重塑和造血。
    • 抑制因素
      • 製造过程成本高
    • 机会
      • 广泛的适应症和可用的药物标靶
      • 生产工艺的进步
    • 任务
      • 摄取激活素 A 可能产生的副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章 激活素 A 市场：按类型

  • 人类激活素A
  • 激活素A小鼠/大鼠

第 7 章 激活素 A 市场：依应用分类

  • 学术研究
  • 商业调查

第八章 Activin A 美洲市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区Activin A市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲Activin A市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Ajinomoto Co., Inc.
  • Ansh Labs, LLC
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • Cell Guidance Systems LLC
  • CellGenix GmbH
  • Enzo Life Sciences, Inc.
  • Merck KGaA
  • Miltenyi Biotec, Inc.
  • PeproTech, Inc.
  • Proteintech Group Inc.
  • Qkine Ltd.
  • RayBiotech, Inc.
  • STEMCELL Technologies Inc.
  • StemRD Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-035DA3C6369C

The Activin-A Market was valued at USD 262.80 million in 2023, expected to reach USD 287.73 million in 2024, and is projected to grow at a CAGR of 9.57%, to USD 498.54 million by 2030.

Activin-A is a member of the TGF-beta superfamily, known for its pivotal role in regulating various physiological processes, including inflammation, cell growth, apoptosis, and tissue repair, making it a significant focus in pharmaceuticals and biotechnology sectors. The market scope encompasses its necessity in therapeutic applications, particularly in fibrotic diseases, cancer, reproductive health, and bone disorders. Predominantly utilized in medical research and clinical trials, Activin-A serves as an experimental agent for studying molecular pathways, thereby offering substantial end-use prospects in academia, pharmaceutical companies, and biotechnology firms. Growth in the Activin-A market is primarily influenced by increasing biomedical research, growing interest in targeted therapies, and an expanding understanding of pathophysiological conditions. The latest opportunities lie in advancing gene therapy and personalized medicine, where Activin-A could be leveraged to develop novel treatments, particularly in rare diseases and chronic inflammatory conditions. Companies can seize these opportunities by engaging in collaborative research, investing in R&D for pharmaceutical applications, and forging alliances with academic institutions to stay abreast of breakthroughs in this niche. However, challenges such as stringent regulatory protocols, high costs of R&D, and limited awareness among healthcare professionals regarding its potential applications may hinder market growth. The current market is ripe for innovation in non-invasive diagnostic tools and the development of biosimilars that can optimize the therapeutic utility of Activin-A. Identifying biomarkers associated with Activin-A pathways could open new avenues for research and application, addressing unmet needs in disease diagnostics and translational medicine. Overall, the market for Activin-A remains nascent yet dynamic, necessitating continuous investment in innovation and strategic partnerships to leverage emerging opportunities amidst potential regulatory and cost barriers.

KEY MARKET STATISTICS
Base Year [2023] USD 262.80 million
Estimated Year [2024] USD 287.73 million
Forecast Year [2030] USD 498.54 million
CAGR (%) 9.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Activin-A Market

The Activin-A Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for cell therapy
    • Benefits provided by activin A such as mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis
  • Market Restraints
    • High cost of manufacturing process
  • Market Opportunities
    • Broad range of sub-indications and available drug targets
    • Increasing advancements in the production process
  • Market Challenges
    • Probable side effects due to consumption of activin A

Porter's Five Forces: A Strategic Tool for Navigating the Activin-A Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Activin-A Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Activin-A Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Activin-A Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Activin-A Market

A detailed market share analysis in the Activin-A Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Activin-A Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Activin-A Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Activin-A Market

A strategic analysis of the Activin-A Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Activin-A Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Ansh Labs, LLC, Bio-Techne Corporation, BioLegend, Inc., Cell Guidance Systems LLC, CellGenix GmbH, Enzo Life Sciences, Inc., Merck KGaA, Miltenyi Biotec, Inc., PeproTech, Inc., Proteintech Group Inc., Qkine Ltd., RayBiotech, Inc., STEMCELL Technologies Inc., StemRD Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Activin-A Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Activin A Human and Activin A Mouse/ Rat.
  • Based on Application, market is studied across Academic Research and Commercial Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for cell therapy
      • 5.1.1.2. Benefits provided by activin A such as mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of manufacturing process
    • 5.1.3. Opportunities
      • 5.1.3.1. Broad range of sub-indications and available drug targets
      • 5.1.3.2. Increasing advancements in the production process
    • 5.1.4. Challenges
      • 5.1.4.1. Probable side effects due to consumption of activin A
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Activin-A Market, by Type

  • 6.1. Introduction
  • 6.2. Activin A Human
  • 6.3. Activin A Mouse/ Rat

7. Activin-A Market, by Application

  • 7.1. Introduction
  • 7.2. Academic Research
  • 7.3. Commercial Research

8. Americas Activin-A Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Activin-A Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Activin-A Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ajinomoto Co., Inc.
  • 2. Ansh Labs, LLC
  • 3. Bio-Techne Corporation
  • 4. BioLegend, Inc.
  • 5. Cell Guidance Systems LLC
  • 6. CellGenix GmbH
  • 7. Enzo Life Sciences, Inc.
  • 8. Merck KGaA
  • 9. Miltenyi Biotec, Inc.
  • 10. PeproTech, Inc.
  • 11. Proteintech Group Inc.
  • 12. Qkine Ltd.
  • 13. RayBiotech, Inc.
  • 14. STEMCELL Technologies Inc.
  • 15. StemRD Inc.
  • 16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ACTIVIN-A MARKET RESEARCH PROCESS
  • FIGURE 2. ACTIVIN-A MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACTIVIN-A MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACTIVIN-A MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ACTIVIN-A MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ACTIVIN-A MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACTIVIN-A MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACTIVIN-A MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACTIVIN-A MARKET DYNAMICS
  • TABLE 7. GLOBAL ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACTIVIN-A MARKET SIZE, BY ACTIVIN A HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACTIVIN-A MARKET SIZE, BY ACTIVIN A MOUSE/ RAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACTIVIN-A MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACTIVIN-A MARKET SIZE, BY COMMERCIAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ACTIVIN-A MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ACTIVIN-A MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. ACTIVIN-A MARKET, FPNV POSITIONING MATRIX, 2023